CTKB vs XYL · rev $92.3M vs P/E 27, rev $4.46B
Cytek Biosciences Inc (CTKB) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported CTKB revenue for 2026-06-30 was $92.3M. Net income was -$31.0M. CTKB currently screens at market cap $421.8M.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
CTKB currently screens at market cap $421.8M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the CTKB and XYL stock pages for the full models.
Not investment advice.